<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 160 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page159.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=160">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 160 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 160</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=160"><img src="../thumb/160.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.7.2                                                 2020-04 / 129
       Indications: Reduct.of elev.tot.cholester.& LDL-cholester.in prim.  stroke, withdr. ther. in case of ser.liv.inj.with clinic.sympt.&/ hyper-  Concom.ther: Bile acid sequestr: Admin.1 hr. bef. / 4 hrs.aft.
       hypercholesterolaem./ heterozygous familial hypercholesterolaem./  bilirubinaem./ jaund.occurs, risk fact. predispos. to ren.fail.second.  cholestyramine.
       mix. hyperlipidaem.when respons.to diet & other nonpharmacolog.  to rhabdomyolys., CK lev. to be meas.if pt.develop.musc. tendern.  Contraindications: Ac./chron.liv.dis., unexplain. persist.serum
       meas.inadeq., reduc.coron. death/non-fat.MI/risk for undergo.myo-  dur. ther./ with concom.niacin.or immunosuppress. agents., sev.ren.  transaminas.elev., porphyr., pregn. & lactat., female pts.of child-
       card. revasculat.proced.& slow.coron.artheroscleros. progress in pts.  funct.impairm., lact.intol.  bear.potent., safety & effic.in paed.pts.not est., concom.meds.inhibit.
       with est. coron. heart dis.& hypercholesterolaem. unrespons.to diet.  Interactions: Incr.plasma lev.with cytochrome P450 3A4 inhibits./  P450 CYP3A4 e.g. cyclospor./itraconazole/ ketoconazole, erythro-
       (S4) TABS. 37/7.5/0335, 0336, 0337  erythromycin, reduc.plasma conc.with cytochrome P450 3A4 induc.,   myc./clarithromyc/HIV proteas. inhibit.& nefazodone not recomm.
       706714-001: 10 mg, 30, R39,71  incr.AUC with diltiazem, sev. musc.probl.with concom.fucid. acid, incr.  Side effects: GI disturbs., bld.dyscras., skin reacts., alopec., my-
       706715-001: 20 mg, 30, R39,71  warfar.anticoag.eff., plasma conc.of digox. incr., bioavailabil.decr.with   alg., musc.cramps, myopathy, myositis, rhabdomyolys., CNS effs.,
       706716-001: 40 mg, 30, R39,71  bile acid sequest., myopathy risk incr./myosit./ rhabdomyolys./ ac.ren.  paraesthes., periph. neuropathy, hypersens.reacts.incl.lupus-like
       Dosage: In combinat.with cholester.low.diet. Concom.ther: Bile   fail.with concom. immunosuppress./ azole antifung./ciclospor./ gem-  syndr., mass gain.
       acid sequestr: Admin. 1 hr. bef./4hrs.aft.cholestyramine.  fibrozil/ other fibrat./macrolide antibiot./ niacin, decr.plasma conc.  Special precautions: Fetotox.& teratogen.in animals, incr.myo-
       Hypercholesterolaem: Init: 10 mg/day as sngl. dos. in even.  with antacids, incr.AUC of norethindrone/ethinyloestrad., poss.incr.   pathy risk with concom.meds. caus.myopathy, outweigh benef.-risk
       Coron.heart dis: Init: 20 mg/day as sngl.dos.in even.  bioavailabil. with inhibits.of OATP1B1 transp.syst., incr. conc.by 2,5-  with concom. immunosuppress./fibrates/lipid.low. niacin. dos.& do
       Dos.adjustm: Adjust dos.if reqd.at interv.of not less than 4 wks., to   3,3 fold with grapefruit juice.  not exceed dos of 10 mg/day, determine INR when init.ther.monit.dur.
       a max.of 80 mg/day as sngl. dos.in even.                   early ther. with concom.coumar. anticoags.& when adjust.dos., sev.
       Contraindications: Other HMG-CoA reduct. inhibit.hypersens., ac./  ATORVASTATIN WINTHROP, Zentiva [P/S]  ren.insuffic., substant.alcoh. consumpt., liv.dis.hist., predisposit.to de-
       chron.liv.dis., unexplain. persist.serum transaminas.elev., porphyr.,   Atorvastatin.  velop. ren.fail.second.to rhabdomyolys., LFT advis.bef. start. treatm.&
       pregn. & lactat., female pts.of child-bear.potent.  Indications: Adjunct.to diet & where other non-pharmacolog. meas.  period.until 1 yr.aft.last dos. escalat., discont.in case of persist.ser.
       Side effects: GI disturbs., anaem., neutropen., skin reacts., alo-  inadeq.to reduc.elev.tot.-cholesterol/ LDL-cholestrol/apolipoprot.B &   transamin. lev. incr./incr.3x or more of upper limit of norm., monit. for
       pec., myalg., musc.cramps, myopathy, rhabdomyolys., CNS effs.,   triglyceride levs.in prim.hypercholesterolaem. /mix. dyslipidaem.&   myopathy & discont.if it occurs/ suspect., withdr.tempor.in pts receiv.
       paraesthes., periph. neuropathy, hypersens.reacts.incl.lupus-like   heterozygous familial hypercholesterolaem., reduc.tot.-cholesterol   cyclospor.if system. azole derivat.antifung.reqd.
       syndr., mass gain.            & LDL-cholesterol in homozygous familial hypercholesterolaem.as   Drug interactions: Meds.inhibit.P450 CYP3A4 poss.incr.plasma lev.
       Special precautions: Fetotox.& teratogen.in rats, incr.myopathy   adjunct to other lipid low. treatm.or if such treatm.unavail.  incr.myopathy risk, digoxin lev.incr., anticoag. eff.of coumar.anticoags.
       risk with concom.meds. caus. myopathy, outweigh benef.-risk with   (S4) TABS. 43/7.5/0480, 0481, 0482  incr., bile acid sequestr. decr.bioavail.
       concom. immunosuppress./ fibrates/lipid.low.niacin.dos.& do not   716615-001: 10 mg, 30, R34,20
       exceed dos of 10 mg/day, determ.INR when init. ther.& monit.dur.  716616-001: 20 mg, 30, R36,29  CADUET, Pfizer Laboratories (Pty) Ltd
       early ther.with interv.usually recomm.for pts.on coumar.anticoags.,   716617-001: 40 mg, 30, R63,60  See Section 7.3.10
       sev.ren. impairm., substant.alcoh.consumpt., liv.dis.hist., predispos-  Dosage: Cholesterol low.diet in place. Dos. determin. indiv.accord.  CHOLESTE, (Unicorn) Be-Tabs [P/S]
       it.to develop. ren.fail.second.to rhabdomyolys., LFT advis. bef.start.  to start.LDL cholestrol lev., treatm.aim & pt.respons.  Simvastatin.
       treatm.& period. until 1 yr.aft.last dos.escalat., discont.in case of per-  Usual start.dos: 10 mg as sngl.dly.dos. Adjust dos. at interv.of 4 wks.  Indications: In combinat with diet to decr.elev. ser.tot.cholester.&
       sist.ser.transamin.lev.incr., monit.for myopathy & discont.if myopa-  or more. Max.dos: 80 mg once dly.  LDL-cholester.in prim. hypercholesterolaem./ heterozyg.familial hy-
       thy occurs/suspect., withdr. tempor.in pts receiv.cyclospor.if system.   Concom.ciclosporine: Dos.not to exceed 10 mg.  percholesterolaem./mix.hyperlipidaem.when respons.to diet & other
       azole derivat.antifung.reqd., concom.meds.inhibit. P450 CYP3A4 e.g.   Prim.hypercholesterolaem.& combin.(mix.) hyperlipidaem:   nonpharmacolog.meas. inadeq., reduc.risk of tot.mortal.by reduc.cor-
       cyclospor./itraconazole/ ketoconazole/erythromyc/clarithromyc./HIV   10 mg once dly. Therap.respons. within 2 wks.& max.respons.usual.  on. death/reduc.risk of non-fat.MI/reduc.risk of myocard. revasculat.
       proteas. inhibit.not recomm., lact.intol.  achiev.within 4 wks. Respons.maint.dur.chron.ther.  proced.& slow.coron. artheroscleros. progress in pts.with coron.heart
       Drug interactions: Meds.inhibit.P450 CYP3A4 poss.incr.plasma   Heterozygous familial hypercholesterolaem.: Init.10 mg dly.   dis.& hypercholesterolaem. unrespons.to diet.
       lev., digoxin lev.incr., anticoag. eff.of coumar.anticoags.incr., bile acid   Indiv.& adjust every 4 wks.to 40 mg dly. Thereaft.bile acid sequestr.  (S4) TABS. 41/7.5/0391, 0392, 0393
       sequestr. decr.bioavail., myopathy/rhabdomyolys.risk incr.by concom.  maybe combin.  715708-001: 10 mg, 28, R33,60
       amiodarone/verapamil at high simvastat. dos. when max.simvastat.  Homozygous familial hypercholesterolaem: As compass.use   714705-001: 20 mg, 30, R34,80
       dos.of 20 mg/day recomm.      in uncontrol.study most pts. Respond. to 80 mg.  714706-001: 40 mg, 30, R37,23
                                     Contraindications: Act.liv.dis./persist. unexplain. elev.ser.transami-
       ASTOR, (Cipla) Watson [P/S]   nas.exceed.3x norm.value, pregn., lactat., women of childbear.potent.  Dosage: Cholestr.low.diet bef.init.& dur.ther.
       Atorvastatin                  not using adeq.contracept., safety & effic.in childr. not est., heredit.  Hypercholesterolaem: Adults: Init.10 mg/day as sngl.dos. in even.
                                                                  Reduc.dos.if LDL-cholester lev. falls below 1,94 mmol/L or tot.plasma
       Indications: Adjunct.to diet to reduc.elev.tot.-cholesterol/ LDL-  galact.intol., Lapp lactase defic., gluc-galact.malabsorpt.
       cholesterol/ apolipoprot.B & triglyceride levs.in prim.hypercholes-  Side effects: GI disords., thrombocytopaen., allerg. reacts.incl.ana-  cholester. lev.falls below 3,6 mmol/L.
                                                                  Coron.heart dis: Adults: Init.20 mg/day as sngl. dos.in even. Adjust
       terolaem./ heterozygous familial hypercholesterolaem. & mix. dys-  phylax., alopec., hypo-/hyperglycaem., pancreatit., insomn., amnes.,
       lipidaem., reduc.tot.-cholesterol & LDL-cholesterol in homozygous   headache, light-headedn., paraesthes., hypoaesthes., periph.neurop-  dos.if reqd.at interv.of not less than 4 wks.up to a max.of 80 mg/day
                                                                  as sngl.dos. in even.
       familial hypercholesterolaem. as adjunct to other lipid low.treatm.  athy, hepatit., cholestat.jaund., skin reacts.incl.erythema multiforme/  Concom.ther: Bile acid sequestr: Admin.1 hr. bef./ 4 hrs.aft.
       or if such treatm.unavail.    Stev.John.syndr./tox.epiderm. necrolys., angioneurot.oed., tinnit., ar-
       (S4) TABS. 44/7.5/1054, 1055, 1056, 1057  thralg., myalg., myopathy, miosit., rhabdomyolys.with/ without ren.  cholestyramine. Cyclosporine, fibrates or niacin: Max.recomm.
                                                                  dos: 10 mg/day.
       719185-001: 10 mg, 30, R33,60  impairm., impot., asthen., chest & back pain, periph.oed., malaise,
       719186-001: 20 mg, 30, R36,11  weight gain, hypoaesthes., dizzin., tinnit.  Contraindications: Ac./chron.liv.dis., unexplain. persist.serum
                                                                  transaminas.elev., safety in porphyr. not est., female pts.of child-
       719187-001: 40 mg, 30, R61,20  Special precautions: Excl.second.caus.& meas. lipid profile prior
       719189-001: 80 mg, 30, R122,70  to init.ther., monit.liv.funct.bef.& dur.treatm., withdr.if ALT & AST per-  bear. potent., safety & effic.in paed.pts.not est., safety in pregn.&
                                                                  lactat. not est., concom.meds.inhibit.P450 CYP3A4 e.g. cyclospor./
       Dosage: Cholester.low.diet in place.  sist.&gt;3 times ULN, substant.alcoh.consum., liv.dis.hist., discont. if CPK
       Heterozygous familial hypercholesterolaem. & mix.dys-  lev.mark.elev.or if myopathy is diagn./susp., withdr.in ac./ser.condit.  itraconazole/ketoconazole/erythromyc. / clarithromyc /HIV proteas.
                                                                  inhibit.& nefazodone not recomm.
       lipidaem: Init.10 mg dly. May be adjust. at 4 wk.interv.up to   suggest.of myopathy/risk fact.predispos.to ren.fail.second.to rhabdo-
       max.80 mg dly.                myolys., cons.benef./risk with predispos.rhabdomyolys. fact., CK lev.  Side effects: Bld.dyscras., mass gain, CNS effs., headache, dizzin.,
                                                                  paraesthes., periph.neuropathy, fatig., GI disturbs., pancreatit., skin
       Homozygous familial hypercholesterolaem: 10-80 mg once   to be meas.bef.init.& dur.ther.in high risk rhabdomyolys. pts., monit.
       dly. As adjunct to lipid-lower. treatm.such as LDL apheres.or if such   lipid lev.with diltiazem init./aft.dos.adjustm., large quantit. grapefr.   reacts., alopec., myalg., musc.cramps, asthen., myopathy, rhabdo-
                                                                  myolys., myositis, hypersens. syndr.incl. angioed./lupus-like syndr.
       treatm.are unavail.           juice, incr.atorvastatin-induc.myopathy risk with fibrat.esp.gemfibrozil,
       Cardiovasc.complic.prevent: Usual dos: 10 mg once dly.  concom.digoxin/OC /warfar.& cytochrome P450 3A4 inhibits., allow   incl.polymyalg. rheumat./ vasculit./incr.ESR, thrombocytopen./ eo-
                                                                  sinophil./ arthralg./urticar./photosens./fev./ flush./malaise dyspn.
       Contraindications: Other HMG-CoA reductase inhibit. hypersens.,   1 mnth. interv.aft.discont.ther.bef.plann.pregn.
       act.liv.dis./persist.unexpl.elev. ser. aminotransferase exceed.3 times   Drug interactions: Myopathy risk incr.with concom. immunosup-  Special precautions: Fetotox.& teratogen.in animals, INR with
                                                                  concom.coumar.anticoags./ when init.ther.unt.stabilis.& dos.adjustm.,
       norm.value, safety & effic.in pregn., lactat.& childr.not est., plann.   press.agents incl.ciclospor./ fibric acid derivat./nicotin.acid/azole anti-  sev.ren. insuff., substant.alcoh.consumpt., liv.dis.hist., predisposit. to
       pregn., pts.with Child-Pugh B & C liv.impairm., concom.rifampicin/  fung./ macrol. antibiot.incl.erythromycin & ezetimibe, incr.plasma lev.  develop.ren.fail.second.to rhabdomyolys., incr.ren.fail.risk in rhabdo-
       diltiazem/ grapefruit juice.  with cytochrome P450 3A4 inhibits. eg.ciclosporine/macrolide antibi-  myolys., sev. ren. impairm., LFT recomm.prior to init.ther.& period.until
       Side effects: Incr.ser.transamin.lev., myopathy, rhabdomyolys. with/  ot.incl. erythromycin & clarithromycin/nefazodone/azole antifung.incl.  1 yr.aft.last dos.elev., discont.in case of persist.ser.transamin.lev.incr.,
       without ren.impairm., bld. dyscras., hypersens.reacts.incl.angioed./   itraconazole & ketoconazole/ amiodarone/ verapamil/HIV protease   incr.myopathy risk with concom.meds.caus.myopathy, unexpl. musc.
       anaphylax., hypo-/hyperglycaem., weight gain, anorex., insomn., diz-  inhibits./ grapefruit juice, incr.AUC with diltiazem, reduc. plasma conc.  pain/weakn./tendern., outweigh benef.-risk with concom.immunosup-
       zin., headache, paraesthes., hypoaesthes., periph.neuropathy, CNS   with cytochrome P450 3A4 induc. eg.efavirenz/ rifampicin/phenytoin/  press./fibrates/lipid.low. niacin. dos.not exceed Choleste 10 mg/day,
       effs.incl. cognit. impairm., blurr.vis., vis.disturbs., tinnit., hear. loss,   St John’s Wort & oral antacids contain.Mg & Al, plasma conc.of di-  monit. for myopathy & discont.if myopathy occurs/ suspect., withdr.
       periph.oed., sinusit., pharyngit., GI disords., dysgeus., pancreatit.,   gox.incr., rais.norethisterone & ethinyl oestradiol plasma lev., plasma   tempor.in pts receiv.cyclospor.if system. azole derivat.antifung.reqd.
       hepatit., cholestat. jaund., hepat.fail., skin reacts.incl.erythema mul-  conc.decr.with colestipol although LDL-C reduct.was great.in combin.  Drug interactions: Meds.inhib.P450 CYP3A4 poss.incr.plasma lev.,
       tiforme/ Stev.John.syndr./tox.epiderm. necrolys., alopec., arthralg.,   ther. than when either med was giv.alone.  digoxin lev.incr., anticoag. eff. of coumar.anticoags.incr., bile acid se-
       myalg., back/chest pain, myopathy, myosit., musc.cramps/weakn.,   quest. poss. decr.bioavail.
       tend. rupt., impot., gynaecomast., fatig., asthen., infect., malaise.  AUSTELL-SIMVASTATIN, Austell [P/S]
       Special precautions: Lipid lower.ther.to be compon.of multip.risk   Simvastatin.  CIPLA SIMVASTATIN, Cipla Medpro [P/S]
       fact.intervent.where atherosclerot. vasc.dis.risk pres., lipid-alter.  Indications: Reduct.of elev.ser.tot.cholester.& LDL-cholester.in prim.  Simvastatin
       agents used in addit.to diet restrict.in saturat.fat & cholester. only   hypercholesterolaem./ heterozyg.familial hyperacholesterolaem./mix.   Indications: Decr.elev.ser.tot.cholester.& LDL-cholester.in prim.
       when respons.to diet & other non-pharmacol. meas.inadeq., excl.  hyperlipidaem. when respons. to diet & other non pharmacolog.meas.  hypercholesterolaem./ heterozygous familial hypercholesterolaem/
       second.caus.prior to init. ther. & meas.lipid profile, adeq.contracept.  inadeq., reduc.risk of tot. mortal. by reduc.coron.death/reduc.risk of   mix. hyperlipidaem. when respons.to diet & other nonpharmacolog.
       in women of childbear.potent., allow 1 mnth.interv. aft. discont.ther.   non-fat. MI/reduc.risk of undergo.myocard. revasculat. proced.&   meas.inadeq., reduc.risk of non-fat.MI/tot.mortality by reduc.coron.
       bef.plann.pregn., monit.liv.funct bef. & dur.treatm.discont.if rise in   slow.coron.artheroscleros. progress in pts.with coron.heart dis.&   death/ slow. progress.of coron.atheroscleros.& reduc. risk of under-
       transamin.lev. persist./ incr.to 3xULN, substant.alcoh.consumpt., liv.   hypercholesterolaem. unrespons.to diet.  go.myocard.revasculat. proced.in coron. heart dis.& hypercholester-
       dis./ ren.impairm.hist., rhabdomyolys.risk, concom. meds.incr.Astor   (S4) TABS. A38/7.5/0477, 0478, 0479  olaem. unrespons. to diet.
       plasma conc., pts.to report unexpl. musc.pain/tendern./weakn.esp.  705464-001: 10 mg, 30, R29,98  (S4) TABS, A40/7.5/0397, 0398, A38/7.5/0370, 0371
       if accomp. by malaise/fev., discont.ther.if CPK lev. mark. elev.or if   705465-001: 20 mg, 30, R33,32  708307-001: 10 mg, 30, R33,60
       myopathy is diagn., concom. immunosuppress./ fibrat./lipid-lower.  705467-001: 40 mg, 30, R38,72  708308-001: 20 mg, 30, R34,80
       niacin dos., concom. ciclospor./ itraconazole/ ketoconazole/ eryth-  Dosage: Adhere to cholester.-low.diet bef.init.& dur.ther.  710511-001: 40 mg, 30, R36,64
       romycin/ clarithromycin/ HIV-protease inhibits./ nefazodone not   Hypercholesterolaem: Init.10 mg/day as sngl. dos.in even. Reduc.  710513-001: 80 mg, 30, R111,61
       recomm., withdr.ther. with concom.ciclosporin, monit.with concom.   dos.if LDL-cholester.lev. falls below 1,94 mmol/L or tot.plasma cho-  Dosage: Cholest.low.diet bef.init.& dur.ther. Adjust dos.if reqd.at
       fucid. acid & withdr.ther.if appropr., concom. warfar./ digoxin/OC,   lester. lev. falls below 3,6 mmol/L  interv.of not less than 4 wks., to max.80 mg dly.in even.as sngl.dos.
       admin.1 hr.bef.or 4 hrs.aft. cholestyram., pts.without coron.heart dis.  Coron.heart dis: Init. 20 mg/day as sngl.dos.in even. Adjust dos.  Hypercholesterolaem: Adults: Init.10 mg dly. in even.as sngl.dos.
       who had stroke/ TIA with.preced.mnths.& were init.on Astor 80 mg ,   if reqd.at interv.of not less than 4 wks.to a max.of 80 mg/day as   Reduc.dos.if LDL-cholester. lev. fall bel.1,94mmol/L or tot.plasma lev.
       haemorrh.stroke pts.on entry appear to be at risk for recurr.haemorrh.  sngl.dos. in even.  fall bel. 3,6 mmol/L.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page159.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page155.html">155</a>&nbsp;&nbsp;&nbsp;<a href="page156.html">156</a>&nbsp;&nbsp;&nbsp;<a href="page157.html">157</a>&nbsp;&nbsp;&nbsp;<a href="page158.html">158</a>&nbsp;&nbsp;&nbsp;<a href="page159.html">159</a>&nbsp;&nbsp;&nbsp;<a href="page160.html">160</a>&nbsp;&nbsp;&nbsp;<a href="page161.html">161</a>&nbsp;&nbsp;&nbsp;<a href="page162.html">162</a>&nbsp;&nbsp;&nbsp;<a href="page163.html">163</a>&nbsp;&nbsp;&nbsp;<a href="page164.html">164</a>&nbsp;&nbsp;&nbsp;<a href="page165.html">165</a>
             </td>
             <td width="35%"><a href="page161.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page161.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
